StockWatch
·

Valiant Laboratories Ltd

BSE: 543998

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
72.85
-1.9%+55.5%
Expenditure
70.95
+15.3%+52.3%
Net Profit
1.45
-84.7%+772.5%
OPM %
2.95%
-14.07pp+2.82pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-15.619.2734.1559.0283.90Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Valiant Labs Q1FY27: consolidated PAT surges ~11x YoY to Rs 21.1 Cr as margins triple

specialty chemicals · subsidiary consolidation · margin expansion

ResultsQ1 FY2710 Aug 20263 minMetals & Mining
Latest

Corporate Events

Board MeetingVALIANTLAB
2026
2Nov

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingVALIANTLAB
2026
28Sep

Board Meeting

The 5th Annual General Meeting ("AGM") is scheduled to be he…

BSE Filing ↗
Board MeetingVALIANTLAB
2026
17Sep

Board Meeting

The Board of Directors approved the proposed acquisition and…

BSE Filing ↗
Board MeetingVALIANTLAB
2026
10Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingVALIANTLAB
2024
12Nov

Board Meeting

Consider and approve Audited Standalone and Consolidated Fin…

BSE Filing ↗
Board MeetingVALIANTLAB
2024
12Aug

Board Meeting

Approval Of Standalone And Consolidated Audited Financial Re…

BSE Filing ↗
Board MeetingVALIANTLAB
2024
14May

Board Meeting

Consider and approve Standalone and Consolidated Audited Fin…

BSE Filing ↗